EVALUATION OF THE LONG-TERM EFFICIENCY OF THE IMMUNIZATION AGAINST HEPATITIS B IN NATIONAL VACCINATION SCHEDULE
https://doi.org/10.22627/2072-8107-2017-16-4-49-51
Abstract
The analysis of serological efficiency and duration of maintaining specific immunity at the children imparted by various vaccines against hepatitis B within the national calendar of inoculations in the territory of St. Petersburg is submitted. It is revealed that high credits of antibodies (more 100 mME/ml) were more often observed at children in the first 3 years after vaccination (68.2%). Eventually levels of antibodies decreased, and in 5 years protective credits have remained at 84.5% examined, the number of patients with a caption of antibodies less than 10 Mmeml has grown from 8.5 to 15.5%.
About the Authors
I. V. Shilova
Pediatric Research and Clinical Center of Infectious Diseases, Saint-Petersburg
Russian Federation
Russian Federation
PhD
+7(812) 234-34-16
L. G. Goriacheva
Pediatric Research and Clinical Center of Infectious Diseases, Saint-Petersburg
Russian Federation
MD, the head is the leading research assistant of the Division of viral hepatitis and liver disease
Russian Federation
MD, the head is the leading research assistant of the Division of viral hepatitis and liver disease
S. M. Kharit
Pediatric Research and Clinical Center of Infectious Diseases, Saint-Petersburg
Russian Federation
MD, professor, supervisor - leaded of the Department of Infectious Disease Prevention, Children's Scientific
Russian Federation
MD, professor, supervisor - leaded of the Department of Infectious Disease Prevention, Children's Scientific
A. S. Drap
Pediatric Research and Clinical Center of Infectious Diseases, Saint-Petersburg
Russian Federation
Russian Federation
M. A. Okuneva
Management of the Federal Service of Rospotrebnadzor around the city to St. Petersburg, Saint-Petersburg
Russian Federation
Russian Federation
References
1. Горячева Л.Г., И.В. Шилова, С.М. Харит. Течение хронического гепатита В у детей, рожденных от матерей с НВ-вирусной инфекцией. Детские инфекции. 2015; 14(2): 22—24. [Goryacheva L.G, I.V. Shilova, S.M. Harit. The course of chronic hepatitis B in children born to mothers with HBV infection. Detskie Infektsii=Children's infections. 2015; 14 (2): 22—24. (In Russ.)]
2. Accelerating progress on HIV, tuberculosis, malaria, hepatitis and neglected tropical diseases. A new agenda for 2016—2030. World Health Organization, 2015: 64. ISBN 978 92 4 151013 4.
3. Hepatitis B vaccines. WHO position paper Jule 2017/7 JULY 2017, 92th YEAR/No 27, 2017, 92, 369—392. http://www.who.int/wer
4. О реализации Программы элиминации острого вирусного гепатита В на территориях Северо-Западного Федерального окру- га: информационно-методическое письмо.СПБ: ФБУН НИИЭМ имени Пастера, 2016: 12. [On the implementation of the Program for the Elimination of Acute Hepatitis B Virus in the Territories of the North-West Federal District: Information and Methodological Letter. PSP: FBUN NIIEM named after Pasteur, 2016: 12. (In Russ.)]
5. Федеральный закон от 17 сентября 1998 г. № 15 «Об иммунопрофилактике инфекционных болезней». [Federal Law of September 17, 1998, No. 15 «On the immunization of infectious diseases». (In Russ.)]
6. Приказ Минздрава России № 125н от 21.03.2014 г. «Об утверждении национального календаря профилактических прививок и календаря профилактических прививок по эпидемическим показаниям» [Order of the Ministry of Health of Russia No. 125n of March 21, 2014 «On the approval of the national calendar of preventive vaccinations and the calendar of preventive vaccinations for epidemic indications» (In Russ.)]
7. Coppola N., A.R. Corvino, S. De Pascalis, G. Signoriello, E. Di Fiore, A. Nienhaus, E. Sagnelli, M. Lamberti. The long-term mmunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy. BMC Infectious Diseases. 2015; 15:149—156. DOI10.1186/s12879-015-0874-3
8. Организация и проведение серологического мониторинга состояния коллективного иммунитета к инфекциям, управляемым средствами специфической профилактики (дифтерия, столбняк, коклюш, корь, краснуха, эпидемический паротит, полиомиелит, гепатит В): Методические указания. М.: Федеральный центр гигиены и эпидемиологии Роспотребнадзора, 2011:19. [Organization and conduct of serological monitoring of the state of collective immunity to infections controlled by means of specific prevention (diphtheria, tetanus, whooping cough, measles, rubella, mumps, poliomyelitis, hepatitis B): Methodological guidelines. Moscow: Federal Center for Hygiene and Epidemiology of Rospotrebnadzor, 2011: 19. (In Russ.)]
9. Streinu-Cercel O., A. Streinu-Cercel, L. Preoţescu et al. Hepatitis B virus vaccination status of sixth year medical students. BMC Infectious Diseases. 2013, 13(Suppl 1):29.
10. Schillie S., T. Walker, S. Veselsky, S. Crowley, C. Dusek et al. Outcomes of Infants Born to Women. PEDIATRICS. May 2015; 135(5).
Review
For citations:
Shilova I.V., Goriacheva L.G., Kharit S.M., Drap A.S., Okuneva M.A. EVALUATION OF THE LONG-TERM EFFICIENCY OF THE IMMUNIZATION AGAINST HEPATITIS B IN NATIONAL VACCINATION SCHEDULE. CHILDREN INFECTIONS. 2017;16(4):49-51. (In Russ.) https://doi.org/10.22627/2072-8107-2017-16-4-49-51
Views:
751
Email this article 